Nasal spray shows promise in rapidly reducing suicidal thoughts
NCT ID NCT07199179
Summary
This study aims to understand how a nasal spray medication called esketamine helps reduce suicidal thoughts in people with severe depression. Researchers are analyzing data from 456 patients who previously received esketamine in clinical trials to see if factors like emotional pain or loss of pleasure predict who benefits most. The goal is to better target this treatment for those experiencing suicidal thoughts alongside depression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUICIDE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chu Montpellier
Montpellier, France
Conditions
Explore the condition pages connected to this study.